1
|
Kleinig TJ, Abou-Hamden A, Laidlaw J, Churilov L, Kellner CP, Wu T, Mocco J, Lau H, Adamides A, Kavar B, Dimou J, Cranefield J, McDonald A, Plummer S, Davis S, Campbell BCV. Early minimally invasive intracerebral hemorrhage evacuation: a phase 2a feasibility, safety, and promise of surgical efficacy study. J Neurointerv Surg 2024; 16:555-558. [PMID: 37611941 DOI: 10.1136/jnis-2023-020446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Accepted: 06/13/2023] [Indexed: 08/25/2023]
Abstract
BACKGROUND Surgical treatment of intracerebral hemorrhage (ICH) is unproven, although meta-analyses suggest that both early conventional surgery with craniotomy and minimally invasive surgery (MIS) may be beneficial. We aimed to demonstrate the safety, feasibility, and promise of efficacy of early MIS for ICH using the Aurora Surgiscope and Evacuator. METHODS We performed a prospective, single arm, phase IIa Simon's two stage design study at two stroke centers (10 patients with supratentorial ICH volumes ≥20 mL and National Institutes of Health Stroke Scale (NIHSS) score of ≥6, and surgery commencing <12 hours after onset). Positive outcome was defined as ≥50% 24 hour ICH volume reduction, with the safety outcome lack of significant ICH reaccumulation. RESULTS From December 2019 to July 2020, we enrolled 10 patients at two Australian Comprehensive Stroke Centers, median age 70 years (IQR 65-74), NIHSS score 19 (IQR 19-29), ICH volume 59 mL (IQR 25-77), at a median of 227 min (IQR 175-377) post-onset. MIS was commenced at a median time of 531 min (IQR 437-628) post-onset, had a median duration of 98 min (IQR 77-110), with a median immediate postoperative hematoma evacuation of 70% (IQR 67-80%). A positive outcome was achieved in 5/5 first stage patients and in 4/5 second stage patients. One patient developed significant 24 hour ICH reaccumulation; otherwise, 24 hour stability was observed (median reduction 71% (IQR 61-80), 5/9 patients <15 mL residual). Three patients died, unrelated to surgery. There were no surgical safety concerns. At 6 months, the median modified Rankin Scale score was 4 (IQR 3-6) with 30% achieving a score of 0-3. CONCLUSION In this study, early ICH MIS using the Aurora Surgiscope and Evacuator appeared to be feasible and safe, warranting further exploration. TRIAL REGISTRATION NUMBER ACTRN12619001748101.
Collapse
Affiliation(s)
- Timothy J Kleinig
- Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
- Medicine, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
| | - Amal Abou-Hamden
- Neurosurgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia
- Surgery, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
| | - John Laidlaw
- Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia
- Surgery, The University of Melbourne, Melbourne, Victoria, Australia
| | - Leonid Churilov
- Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | | | - Teddy Wu
- Neurology, Christchurch Hospital, Christchurch, Canterbury, New Zealand
| | - J Mocco
- Neurosurgery, Mount Sinai Health System, New York, New York, USA
| | - Hui Lau
- Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - Alexios Adamides
- Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - Bhadrakant Kavar
- Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - James Dimou
- Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - Jennifer Cranefield
- Department of Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
| | - Amy McDonald
- Neurology, Royal Melbourne Hospital, Parkville, Victoria, Adelaide, Australia
| | - Stephanie Plummer
- Neurosurgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia
| | - Stephen Davis
- Medicine, The University of Melbourne, Melbourne, Victoria, Australia
- Neurology, Royal Melbourne Hospital, Parkville, Victoria, Adelaide, Australia
| | - Bruce C V Campbell
- Medicine, The University of Melbourne, Melbourne, Victoria, Australia
- Neurology, Royal Melbourne Hospital, Parkville, Victoria, Adelaide, Australia
| |
Collapse
|
2
|
Hopkins K, Price B, Ziogas J, Adamides A, Mangum J. Comparative proteomic analysis of ventricular and cisternal cerebrospinal fluid in haemorrhagic stroke patients. J Clin Neurosci 2023; 107:84-90. [PMID: 36525746 DOI: 10.1016/j.jocn.2022.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 11/04/2022] [Accepted: 11/10/2022] [Indexed: 12/23/2022]
Abstract
BACKGROUND Analysis of cerebrospinal fluid (CSF) using mass spectrometry is a relatively novel analytical tool, and comparisons of ventricular and cisternal proteomes are yet to be performed. This may have implications for clinical medicine, particularly in demonstrating continuity of the ventricular system with preserved flow in the presence of ventricular blood. Other uses include the identification of novel biomarkers, including for diagnosis of subarachnoid haemorrhage and of aetiology. The primary objective was therefore to characterise and compare the proteomes of ventricular and CSF after haemorrhagic stroke. METHODS Paired CSF samples were prospectively collected from the optico-carotid cistern and the frontal horn of the lateral ventricle at the time of craniotomy and clipping in 8 patients with haemorrhagic stroke. Six patients had an aneurysmal subarachnoid haemorrhage (aSAH) from a ruptured saccular aneurysm, one patient had an aSAH after rupture of a mycotic aneurysm and one patient had a spontaneous intracerebral haemorrhage (IPH) with an adjacent unruptured saccular aneurysm. Samples were processed and proteins identified and quantified using data-dependent liquid chromatography tandem mass spectrometry (DDA LC-MSMS). RESULTS There was no systematic difference between the cisternal and ventricular proteomes. However, blinded principal component analysis (PCA) of the cisternal and ventricular samples separated patients according to pathophysiology. Additionally CSF D-Dimer levels were not detected in the IPH patient but were reliably measured in aSAH patients. CONCLUSIONS Ventricular CSF is representative of cisternal CSF after aSAH. CSF proteomic PCA analysis can distinguish between haemorrhage types. CSF D-dimer levels may represent a novel diagnostic marker for aSAH. Label free DDA LC-MSMS CSF analysis may inform possible biomarkers.
Collapse
Affiliation(s)
- Katherine Hopkins
- Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia
| | - Benjamin Price
- Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
| | - James Ziogas
- Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia
| | - Alexios Adamides
- Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, VIC, Australia
| | - Jonathan Mangum
- Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia
| |
Collapse
|
3
|
Winter CD, Adamides A, Rosenfeld JV. The role of decompressive craniectomy in the management of traumatic brain injury: a critical review. J Clin Neurosci 2005; 12:619-23. [PMID: 16033709 DOI: 10.1016/j.jocn.2005.02.002] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2004] [Accepted: 02/08/2005] [Indexed: 12/01/2022]
Abstract
Brain swelling and intracranial hypertension following severe head injury are known to contribute to secondary brain damage, and have been shown to adversely affect patient outcome. The use of unilateral craniectomy following the evacuation of a mass lesion, such as acute subdural haematoma or traumatic intracerebral haematoma, is accepted practice. The following review focuses on a bi-fronto-temporal decompressive craniectomy, used as an isolated operation for the control of intracranial hypertension, secondary to diffuse brain swelling refractory to medical management. Though the operation is being increasingly used, current opinion is still divided regarding its overall effects on outcome. This review examines the experimental and clinical evidence for and against the use of decompressive craniectomy, highlights the lack of class I evidence relevant to this topic and emphasises the necessity for well-designed prospective randomised controlled trials.
Collapse
Affiliation(s)
- C D Winter
- Department of Neurosurgery, The Alfred Hospital, Melbourne, Victoria, Australia.
| | | | | |
Collapse
|